Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from EC Healthcare ( (HK:2138) ).
EC Healthcare has issued a supplemental announcement to its annual report for the year ended 31 March 2025, detailing additional information on its share award scheme adopted in June 2016. The company clarified the scheme’s limits, vesting conditions and compliance framework, underscoring its approach to staff incentives and alignment with Hong Kong listing rules.
The board confirmed that the total number of award shares available for future grants as at 31 March 2025 was 111,324,126, after 7,197,000 shares previously granted under the scheme were either vested or forfeited. EC Healthcare also emphasized that any future awards will observe a minimum 12-month vesting period and require no payment on application or acceptance, reinforcing long-term employee retention while meeting updated regulatory requirements.
The most recent analyst rating on (HK:2138) stock is a Hold with a HK$0.65 price target. To see the full list of analyst forecasts on EC Healthcare stock, see the HK:2138 Stock Forecast page.
More about EC Healthcare
EC Healthcare, incorporated in the Cayman Islands and listed in Hong Kong, operates as a healthcare services group. The company provides medical and wellness services and uses equity-based incentive tools, such as a share award scheme, to attract and retain employees in a competitive healthcare market.
Average Trading Volume: 371,310
Technical Sentiment Signal: Sell
Current Market Cap: HK$734.8M
Find detailed analytics on 2138 stock on TipRanks’ Stock Analysis page.